Figure 3.
Pretreatment and 4-month post-treatment axial pelvis MRI images with contrast enhancement of the patient treated with oestrogen receptor antagonists. Note tumour shrinking and loss of contrast enhancement on therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.